Enzymatica Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:EN9 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
15 Nov 24	Buy€4,692	Louise Nicolin	Individual	30,610	€0.15
14 Nov 24	Buy€7,423	Louise Nicolin	Individual	47,543	€0.16
11 Nov 24	Buy€8,078	Louise Nicolin	Individual	50,794	€0.16
07 Nov 24	Buy€3,859	Therese Filmersson	Individual	25,000	€0.15
16 Sep 24	Buy€10,310	Bengt Baron	Individual	45,000	€0.23
29 Apr 24	Sell€17,143	Gudmundur Palmason	Individual	68,300	€0.25
26 Apr 24	Sell€37,950	Gudmundur Palmason	Individual	142,000	€0.27
25 Mar 24	Sell€5,266	Gudmundur Palmason	Individual	19,226	€0.28
23 Feb 24	Sell€80,605	Gudmundur Palmason	Individual	300,000	€0.27

Insider Trading Volume

Insider Buying: EN9 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EN9?
Owner Type	Number of Shares	Ownership Percentage
Institutions	32,905	0.0153%
Individual Insiders	45,707,327	21.2%
General Public	170,029,154	78.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.4%.

Top Shareholders

Top 11 shareholders own 21.2% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.9%	Mats Andersson	36,398,195	€5.1m	0%	no data
2.08%	Gudmundur Palmason	4,497,097	€630.3k	-51.7%	no data
1.65%	Bengt Baron	3,552,859	€498.0k	1.28%	no data
0.19%	Therese Filmersson	400,000	€56.1k	6.67%	no data
0.13%	Claus Egstrand	279,453	€39.2k	0%	no data
0.11%	Louise Nicolin	228,947	€32.1k	129%	no data
0.11%	Helene Willberg	228,753	€32.1k	0%	no data
0.039%	Claes Molin	85,023	€11.9k	0%	no data
0.017%	Chris Czyrko	37,000	€5.2k	0%	no data
0.0084%	Elite Fund Management Ltd	18,140	€2.5k	0%	0.03%
0.0068%	FCG Fonder AB	14,765	€2.1k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/09 23:22
End of Day Share Price	2025/01/09 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Enzymatica AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jakob Lembke	ABG Sundal Collier Sponsored
Peter Sellei	Penser Access
Maria Karlsson Osipova	Penser Access